Search Results - "Mahali, Sidhartha"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Advanced Glycation End Products Induce Lipogenesis: Regulation by Natural Xanthone through Inhibition of ERK and NF-κB by Mahali, Sidhartha K., Verma, Neeharika, Manna, Sunil K.

    Published in Journal of cellular physiology (01-12-2014)
    “…ABSTRACT Advanced glycation end products (AGE) accumulate in diabetic patients and aged persons due to high amounts of 3‐ or 4‐carbon derivatives of glucose…”
    Get full text
    Journal Article
  3. 3

    Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration by Mahali, Sidhartha, Martinez, Rita, King, Melvin, Verbeck, Anthony, Harari, Oscar, Benitez, Bruno A., Horie, Kanta, Sato, Chihiro, Temple, Sally, Karch, Celeste M.

    Published in Translational psychiatry (10-12-2022)
    “…Impaired proteostasis is associated with normal aging and is accelerated in neurodegeneration. This impairment may lead to the accumulation of protein, which…”
    Get full text
    Journal Article
  4. 4

    Beta-d-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding by Mahali, Sidhartha K., Manna, Sunil K.

    Published in Biochemical pharmacology (15-12-2012)
    “…Accumulation of advanced glycation end products (AGEs), due to excessive amounts of 3- or 4-carbon sugars derived from glucose; cause multiple consequences in…”
    Get full text
    Journal Article
  5. 5

    A natural xanthone increases catalase activity but decreases NF-kappa B and lipid peroxidation in U-937 and HepG2 cell lines by Sahoo, Binay K., Zaidi, Adeel H., Gupta, Pankaj, Mokhamatam, Raveendra B., Raviprakash, Nune, Mahali, Sidhartha K., Manna, Sunil K.

    Published in European journal of pharmacology (05-10-2015)
    “…Mangiferin, a C-glycosyl xanthone, has shown anti-inflammatory, antioxidant, and anti-tumorigenic activities. In the present study, we investigated the…”
    Get full text
    Journal Article
  6. 6

    Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling by Minaya, Miguel A, Mahali, Sidhartha, Iyer, Abhirami K, Eteleeb, Abdallah M, Martinez, Rita, Huang, Guangming, Budde, John, Temple, Sally, Nana, Alissa L, Seeley, William W, Spina, Salvatore, Grinberg, Lea T, Harari, Oscar, Karch, Celeste M

    Published in Frontiers in molecular biosciences (09-02-2023)
    “…More than 50 mutations in the gene result in heterogeneous forms of frontotemporal lobar dementia with tau inclusions (FTLD-Tau). However, early pathogenic…”
    Get full text
    Journal Article
  7. 7

    Defective proteostasis in patient‐derived iPSC‐astrocytes and neurons carrying a MAPT IVS10+16 mutation by Mahali, Sidhartha, Karch, Celeste

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Impaired proteostasis is associated with normal aging and is accelerated in neurodegeneration. This impairment may lead to the toxic protein…”
    Get full text
    Journal Article
  8. 8

    Defective proteostasis in patient‐derived iPSC astrocytes and neurons carrying a MAPT IVS10+16 mutation by Mahali, Sidhartha, Martinez, Rita, Hu, Miwei, Marsh, Jacob, Temple, Sally, Karch, Celeste M.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Impaired proteostasis is associated with normal aging and is accelerated in neurodegeneration. This impairment may lead to the toxic accumulation of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Advanced Glycation End Products Induce Lipogenesis: Regulation by Natural Xanthone through Inhibition of ERK and NF-[kappa]B by Mahali, Sidhartha K, Verma, Neeharika, Manna, Sunil K

    Published in Journal of cellular physiology (01-12-2014)
    “…Advanced glycation end products (AGE) accumulate in diabetic patients and aged persons due to high amounts of 3- or 4-carbon derivatives of glucose…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Functional characterization of hiPSCs‐derived glial cells and neurons from patients harboring a TREM2 loss of function mutation by Filipello, Fabia, You, Shih‐Feng, Martinez, Rita, Korvatska, Olena, Raskind, Wendy H, Mahali, Sidhartha, Ghezzi, Laura, Wandy, Beatty, Cella, Marina, Piccio, Laura, Karch, Celeste M.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor expressed by microglia in the adult brain. Homozygous loss of…”
    Get full text
    Journal Article